• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Impac Software Collaborates With the National Comprehensive Cancer Network to Improve Patient Care

Posted on: Tuesday, 17 February 2009, 08:00 CST

SUNNYVALE, Calif., Feb. 17 /PRNewswire/ -- Impac Software, part of the Elekta Group, today announced its collaboration with the National Comprehensive Cancer Network (NCCN) to license NCCN's clinical care content to clinicians utilizing MOSAIQ(R), Impac's oncology electronic medical record (EMR).

MOSAIQ will be the first oncology EMR to embed an intelligent search engine that dynamically links to the NCCN Clinical Practice Guidelines in Oncology(TM). The NCCN Guidelines are used by clinicians to shape care recommendations covering 97 percent of all patients with cancer and are updated on a continual basis. The NCCN Guidelines, developed through an explicit review of evidence and recommendations from medical experts, address cancer detection, prevention and risk reduction, workup and diagnosis and treatment and supportive care.

In addition, MOSAIQ also will provide active access to the NCCN Drugs & Biologics Compendium(TM), which delineates uses of drugs and biologics in the care of patients with cancer, listing FDA-approved disease indications as well as off-label recommendations for use, and to the NCCN Chemotherapy Order Templates(TM).

"NCCN is looking forward to working with Impac Software to provide another important channel for distribution of the NCCN Guidelines," says William T. McGivney, PhD, NCCN Chief Executive Officer. "As a result, clinicians will be provided with ready access to the best possible treatment options to improve outcomes for all patients with cancer."

"Simplified, real-time access to NCCN's evidence-based clinical content is expected to enhance the delivery of standardized care and improve patient safety," says Joel Goldwein, M.D., Vice President of Medical Affairs for the Elekta Group. "Many of Impac's customers are NCCN Member Institutions; however simplifying access to NCCN's clinical content will significantly increase the use of NCCN Guidelines throughout Impac Software's existing customer base, and in hundreds of cancer care centers."

About MOSAIQ(R)

Fundamentally integrated to manage the nuances of both medical and radiation oncology charting, Impac Software's comprehensive EMR, MOSAIQ provides a clear, fast and flexible means of documenting patient information throughout the medical assessment and chemotherapy administration process. With the ability to include diagnostic images, lab results, and external documentation, MOSAIQ provides clinicians with a complete picture of patient care. For more information, visit www.impac.com/mosaiq.

About Impac Software

Impac Software is part of the Elekta Group, a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. Impac's open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as systems for anatomic pathology, clinical laboratory and cancer registry.

Today, Elekta solutions are used in more than 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group. Elekta employs around 2,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information, please visit www.impac.com or www.elekta.com.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit www.nccn.org.

SOURCE Impac Software

Source: PR Newswire

More News in this Category